Pattern and determinants of HIV research productivity in sub-Saharan Africa: bibliometric analysis of 1981 to 2009 PubMed papers

Sub-Saharan Africa is more heavily affected by Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) than any other region of the world[1]. Estimated 22.5 million people were living with HIV at the end of 2007 and approximately 1.7 million additional people were infected with HIV during that year[1]. In just the past year, the AIDS epidemic in Africa has claimed the lives of an estimated 1.6 million people in this region. More than 11 million children have been orphaned by AIDS. The rate of growth of AIDS literature has been reported to be of exponential nature [2, 3]. This growth is similar to rapid increase in number of reported cases of AIDS since it was first published in 1981[3]. Several bibliometric studies have been published on AIDS [4–12]. These studies have evolved from descriptive, quantitative analyses of AIDS literature [4, 5], to more qualitative subject and citation analyses. The findings obtained from these studies have provided a general picture of the history and growth of AIDS literature from the unsettled nature of the terminology during the early 1980s[6], to a more structured and controlled Medical Subject Headings (MeSH) terminology [7–12]. Through citation studies, clusters of topics representing networks and maps of AIDS have been obtained[13], and leading institutions and scientists have been identified[14]. However, factors related to variation in HIV research productivity in sub-Saharan Africa have not been examined. Therefore, this study aims to fill some of the gap in existing research to provide insights into factors associated with HIV research productivity in sub-Saharan Africa.

The study shows that HIV research productivity in SSA is highly skewed; South Africa, Uganda, and Kenya jointly account for almost 50% of all HIV/AIDS-related publications in HIV/AIDS indexed in PubMed between 1981 and 2009. This finding is consistent with results from other studies [11, 20, 21]. This study found like others, that the better economic ranking of a country the higher the quantity of itsresearch productivity [20–22]. This study also echoes findings of a previous study that found Malawi tended to most productive when the total HIV publications was normalized by GDP[11]. Falagas and colleagues [8] reviewed the medical literature in order to evaluate the contribution of different world regions on HIV/AIDS research indexed in the Journal Citation Reports (JCR) and the Web of Science databases of the Institute for Scientific Information (ISI). A total of 9502 articles on HIV/AIDS were retrieved from three AIDS journals over an 18-year study period [8]. Falagas et.al. [8] reported that the United States and Western Europe made up a striking 83% and 92% of the world's research production on HIV/AIDS, respectively [8]. About half of articles originating in Latin America and the Caribbean and half in Asia were produced in collaboration with the United States [8]. Only 40% of articles from Africa and 58% from Eastern Europe were produced in cooperation with Western Europe. Falagas et al [8] concluded that collaboration between researchers within developing regions was negligible. Another study recovered a total of 11 826 papers dealing with HIV/AIDS included in the ISI databases in 2003, and found that the leading countries according to the total number of publications were the USA, UK, and France [11]. A bibliometric study regarding AIDS in Latin America and the Caribbean for the period 1980 to 1996 found that while Haiti was the most productive country in the region [10]. Uthman [12] analysed the trends in Nigeria's SCI publications in HIV/AIDS from 1980 to 2006. Uthman [12] found that Nigeria has achieved a significant increase in the number of SCI publications and collaborations in HIV literature and over 85% of the articles were published in collaboration among two or more authors [12]. The USA, as the most important collaborating partner of Nigeria's HIV/AIDS researchers, contributed 30.8% of articles with international collaboration [12].

Evidence from univariable negative binomial regression models suggests that that adult literacy rate, total expenditure on health, and private expenditure on health are the most important predictor of HIV research productivity in sub-Saharan Africa.

For every one log increase in adult literacy rate, the predicted mean HIV productivity increased by 280%. For every one percent of GDP committed to health and one log increase in private expenditure on health, the predicted mean HIV productivity increased by 373% and 445% respectively. Based on the based possible estimates from multivariable negative binomial regression, number of people with HIV, number of indexed journals, total expenditure on health, and private expenditure on health are the main significant factors associated with HIV research productivity in sub-Saharan Africa. A similar finding has been reported previously [23, 24]. Rahman and Fukui studied factors related to worldwide variation in biomedical research productivity[23]. Rahman and Fukui found that gross national product (GNP) per capita and research and development (R&D) expenditure were statistically significantly associated with biomedical research productivity[23]. Another study found that that low gross national product per capita, insufficient number of physicians, and inadequate public spending on the health sector were responsible for the meager number of biomedical publications in Asian countries [24].

In summary, this study examined almost three decades of HIV literature production by first authors from sub-Saharan Africa. The results of the study showed that South Africa, Nigeria, and Uganda were the most productive countries in terms of absolute number of publications indexed by PubMed through the period studied. Based on best possible estimates, number of people with HIV, number of indexed journals, total expenditure on health, and private expenditure on health are the main factors related to HIV research productivity in sub-Saharan Africa.